J Hernández, A Ko, LA Sherman. (2001) "CTLA-4 blockade enhances the CTL responses to the p53 self-tumor antigen." J Immunol 166. 3908-14 PMID: 11238635 | Abstract and Keywords
CA Piccirillo, EM Shevach. (2001) "Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells." J Immunol 167. 1137-40 PMID: 11466326 | Abstract and Keywords
B Gahn, F Siller-Lopez, AD Pirooz, E Yvon, S Gottschalk, R Longnecker, MK Brenner, HE Heslop, E Aguilar-Cordova, CM Rooney. (2001) "Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma." Int J Cancer 93. 706-13 PMID: 11477583 | Abstract and Keywords
JA Sakai, M Nagai, MB Brennan, CA Mora, S Jacobson. (2001) "In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells." Blood 98. 1506-11 PMID: 11520801 | Abstract and Keywords
TN Bullock, DW Mullins, TA Colella, VH Engelhard. (2001) "Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice." J Immunol 167. 5824-31 PMID: 11698456 | Abstract and Keywords
RA Singh, L Wu, MA Barry. (2002) "Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine." J Immunol 168. 379-91 PMID: 11751984 DOI: 11751984 | Abstract and Keywords
TK Hoffmann, DJ Loftus, K Nakano, MJ Maeurer, K Chikamatsu, E Appella, TL Whiteside, AB DeLeo. (2002) "The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope." J Immunol 168. 1338-47 PMID: 11801674 | Abstract and Keywords
MV Maus, AK Thomas, DG Leonard, D Allman, K Addya, K Schlienger, JL Riley, CH June. (2002) "Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB." Nat Biotechnol 20. 143-8 PMID: 11821859 DOI: 10.1038/nbt0202-143 | Abstract and Keywords